Back
Sandfire Resources Vs. Aligos Therapeutics Industry Stock Comparison
Buy
63
SFRRF
Sandfire Resources
Last Price:
6.30
Seasonality Move:
7.73%
Buy
74
ALGS
Aligos Therapeutics
Last Price:
30.61
Seasonality Move:
10.65%
Buy
63
Sandfire Resources (SFRRF)
is a Buy
Is Sandfire Resources a Buy, Sell or Hold?
- The current Sandfire Resources [SFRRF] share price is $6.30. The Score for SFRRF is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
- SFRRF is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
74
Aligos Therapeutics (ALGS)
is a Buy
Is Aligos Therapeutics a Buy, Sell or Hold?
- The current Aligos Therapeutics [ALGS] share price is $30.82. The Score for ALGS is 74, which is 48% above its historic median score of 50, and infers lower risk than normal.
- ALGS is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
SFRRF Stock Price Chart
What is Sandfire Resources's stock price today?
-
The Sandfire Resources share price today is $6.30
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SFRRF is experiencing slight buying pressure.
ALGS Stock Price Chart
What is Aligos Therapeutics's stock price today?
-
The Aligos Therapeutics share price today is $30.82
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALGS is experiencing buying pressure, which is a positive indicator for future bullish movement.
SFRRF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.13 | Sell |
| Relative Strength Index (14 RSI): | 20.99 | Sell |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (6.28 - 6.72) | Sell |
| Bollinger Bands (100): | (5.77 - 6.95) | Sell |
ALGS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.32 | Buy |
| Relative Strength Index (14 RSI): | 81.62 | Buy |
| Chaikin Money Flow: | 315379 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (14.3 - 26.46) | Buy |
| Bollinger Bands (100): | (7.85 - 19.03) | Buy |
SFRRF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 6.3 | Sell |
| 20-day SMA: | 6.44 | Sell |
| 50-day SMA: | 6.83 | Sell |
| 200-day SMA: | 6.13 | Buy |
| 8-day EMA: | 6.31 | Sell |
| 20-day EMA: | 6.43 | Sell |
| 50-day EMA: | 6.54 | Sell |
| 200-day EMA: | 6.04 | Buy |
ALGS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 27.35 | Buy |
| 20-day SMA: | 22.81 | Buy |
| 50-day SMA: | 14.24 | Buy |
| 200-day SMA: | 15.81 | Buy |
| 8-day EMA: | 27.13 | Buy |
| 20-day EMA: | 22.88 | Buy |
| 50-day EMA: | 17.49 | Buy |
| 200-day EMA: | 15.94 | Buy |
Sandfire Resources Earnings Growth & SFRRF Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Aligos Therapeutics Earnings Growth & ALGS Earnings Dates
- Analysts estimate an earnings increase this quarter of $2.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $30.89 per share, and a decrease next year of $2.65 per share.
Sandfire Resources Technical Analysis
| Nov 26 | Nov 27 | Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 26 | 27 | 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Aligos Therapeutics Technical Analysis
| Nov 26 | Nov 27 | Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 26 | 27 | 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||